Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.
Seth WoodfinSierra HallAlexis RamerthBrooke ChappleDane W FausnachtWilliam MooreHana AlkhalidyDongmin LiuPublished in: Nutrients (2024)
Multiple sclerosis (MS) is a chronic autoimmune disorder characterized by inflammation, demyelination, and neurodegeneration, resulting in significant disability and reduced quality of life. Current therapeutic strategies primarily target immune dysregulation, but limitations in efficacy and tolerability highlight the need for alternative treatments. Plant-derived compounds, including alkaloids, phenylpropanoids, and terpenoids, have demonstrated anti-inflammatory effects in both preclinical and clinical studies. By modulating immune responses and promoting neuroregeneration, these compounds offer potential as novel adjunctive therapies for MS. This review provides insights into the molecular and cellular basis of MS pathogenesis, emphasizing the role of inflammation in disease progression. It critically evaluates emerging evidence supporting the use of plant-derived compounds to attenuate inflammation and MS symptomology. In addition, we provide a comprehensive source of information detailing the known mechanisms of action and assessing the clinical potential of plant-derived compounds in the context of MS pathogenesis, with a focus on their anti-inflammatory and neuroprotective properties.
Keyphrases
- multiple sclerosis
- mass spectrometry
- oxidative stress
- white matter
- ms ms
- immune response
- anti inflammatory
- human health
- healthcare
- stem cells
- cell wall
- randomized controlled trial
- clinical trial
- risk assessment
- single molecule
- dendritic cells
- climate change
- blood brain barrier
- bone marrow
- brain injury
- social media
- double blind
- cerebral ischemia